Moreover, TG/manoalide activated more caspase 3/7 activity than manoalide alone in oral cancer cells (CAL 27 and Ca9-22), particularly at a high dose (10 μM) (Figure 5). Here, CASP3 is linked to lip and oral cavity carcinoma.